Amir Mortazavi, MD

Amir Mortazavi


College of Medicine


Internal Medicine

Academic Title


Research Program

Molecular Carcinogenesis and Chemoprevention

Research Interest

Cancer ● Urinary Bladder Cancer ● Leukemia, Myeloid, Acute ● Leukemia, Lymphocytic, Chronic, B-Cell ● Weight Loss ● Colorectal Cancer ● Carcinoma, Renal Cell ● Anorexia ● Leukemia, Promyelocytic, Acute

Amir Mortazavi, MD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on epigenetic modifications and experimental therapeutics for genitourinary cancers.

One of his recent research projects suggests that sorafenib, an oral multikinase inhibitor, could have off-target effects on cytokine-induced signal transduction in immune effector cells.

Dr. Mortazavi has co-authored many articles in well-respected publications, including Cancer Chemotherapy and Pharmacology, Journal of Immunology, Journal of Proteome Research and Journal of Magnetic Resonance Imaging.

Office Location

A441 Starling Loving Hall

320 W 10th Ave, Columbus, OH 43210




Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication